Literature DB >> 16495255

Fluoroquinolone resistance in invasive Streptococcus pyogenes isolates due to spontaneous mutation and horizontal gene transfer.

M W R Pletz1, L McGee, C A Van Beneden, S Petit, M Bardsley, M Barlow, K P Klugman.   

Abstract

Fluoroquinolone resistance in Streptococcus pyogenes has been described only anecdotally. In this study we describe two invasive ciprofloxacin-resistant S. pyogenes isolates (ciprofloxacin MICs, 8 mg/liter), one of which shows evidence of interspecies recombination. The quinolone resistance-determining regions of gyrA and parC were sequenced. In both isolates, there was no evidence for an efflux pump and no mutation in gyrA. Both isolates had an S79F mutation in parC that is known to confer fluoroquinolone resistance. In addition, a D91N mutation in parC, which is not related to fluoroquinolone resistance but is a feature of the parC sequence of Streptococcus dysgalactiae, was found in one isolate. The parC nucleotide sequence of that isolate showed greater diversity than that of S. pyogenes. A GenBank search and phylogenetic analysis suggest that this isolate acquired resistance by horizontal gene transfer from S. dysgalactiae. Statistical testing for recombination confirmed interspecies recombination of a 90-bp sequence containing the S79F mutation from S. dysgalactiae. For the other isolate, we could confirm that it acquired resistance by spontaneous mutation by identifying the susceptible ancestor in an outbreak setting.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495255      PMCID: PMC1426425          DOI: 10.1128/AAC.50.3.943-948.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  MRBAYES: Bayesian inference of phylogenetic trees.

Authors:  J P Huelsenbeck; F Ronquist
Journal:  Bioinformatics       Date:  2001-08       Impact factor: 6.937

2.  Bayesian phylogenetic inference via Markov chain Monte Carlo methods.

Authors:  B Mau; M A Newton; B Larget
Journal:  Biometrics       Date:  1999-03       Impact factor: 2.571

3.  Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae.

Authors:  Luz Balsalobre; María José Ferrándiz; Josefina Liñares; Fe Tubau; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

4.  Clonal spread of fluoroquinolone non-susceptible Streptococcus pyogenes.

Authors:  Surbhi Malhotra-Kumar; Christine Lammens; Sabine Chapelle; Cecile Mallentjer; Joost Weyler; Herman Goossens
Journal:  J Antimicrob Chemother       Date:  2005-02-10       Impact factor: 5.790

5.  Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance.

Authors:  S S Yan; M L Fox; S M Holland; F Stock; V J Gill; D P Fedorko
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

6.  Fluoroquinolone resistance in Streptococcus pyogenes.

Authors:  Sandra S Richter; Daniel J Diekema; Kris P Heilmann; Laurel S Almer; Virginia D Shortridge; Rod Zeitler; Robert K Flamm; Gary V Doern
Journal:  Clin Infect Dis       Date:  2003-01-14       Impact factor: 9.079

7.  Seven years survey of susceptibility to marbofloxacin of bovine pathogenic strains from eight European countries.

Authors:  D Meunier; J-F Acar; J-L Martel; S Kroemer; M Vallé
Journal:  Int J Antimicrob Agents       Date:  2004-09       Impact factor: 5.283

8.  First Streptococcus agalactiae isolates highly resistant to quinolones, with point mutations in gyrA and parC.

Authors:  Yoshiaki Kawamura; Hiromitsu Fujiwara; Noriko Mishima; Yuko Tanaka; Ayako Tanimoto; Shiro Ikawa; Youko Itoh; Takayuki Ezaki
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

9.  Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania.

Authors:  Michael Green; Judith M Martin; Karen A Barbadora; Bernard Beall; Ellen R Wald
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

10.  High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany.

Authors:  R R Reinert; R Lütticken; A Al-Lahham
Journal:  Clin Microbiol Infect       Date:  2004-07       Impact factor: 8.067

View more
  19 in total

1.  First characterization of fluoroquinolone resistance in Streptococcus suis.

Authors:  Jose Antonio Escudero; Alvaro San Millan; Ana Catalan; Adela G de la Campa; Estefania Rivero; Gema Lopez; Lucas Dominguez; Miguel Angel Moreno; Bruno Gonzalez-Zorn
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

2.  Long-term survival of Streptococcus pyogenes in rich media is pH-dependent.

Authors:  Dragutin J Savic; William M McShan
Journal:  Microbiology (Reading)       Date:  2012-02-23       Impact factor: 2.777

3.  Fluoroquinolone resistance in Streptococcus dysgalactiae subsp. equisimilis and evidence for a shared global gene pool with Streptococcus pyogenes.

Authors:  M D Pinho; J Melo-Cristino; M Ramirez
Journal:  Antimicrob Agents Chemother       Date:  2010-02-09       Impact factor: 5.191

4.  Susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada.

Authors:  Samir N Patel; Allison McGeer; Roberto Melano; Gregory J Tyrrell; Karen Green; Dylan R Pillai; Donald E Low
Journal:  Antimicrob Agents Chemother       Date:  2011-05-31       Impact factor: 5.191

5.  Molecular markers for discriminating Streptococcus pyogenes and S. dysgalactiae subspecies equisimilis.

Authors:  D J McMillan; T Vu; P V Bramhachari; S Y Kaul; A Bouvet; M S Shaila; M G Karmarkar; K S Sriprakash
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-12       Impact factor: 3.267

Review 6.  Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Authors:  A Dalhoff
Journal:  Infection       Date:  2012-03-30       Impact factor: 3.553

7.  In Vitro Activity of AZD0914, a Novel Bacterial DNA Gyrase/Topoisomerase IV Inhibitor, against Clinically Relevant Gram-Positive and Fastidious Gram-Negative Pathogens.

Authors:  Douglas J Biedenbach; Michael D Huband; Meredith Hackel; Boudewijn L M de Jonge; Daniel F Sahm; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2015-07-20       Impact factor: 5.191

8.  Interspecies recombination occurs frequently in quinolone resistance-determining regions of clinical isolates of Streptococcus pyogenes.

Authors:  Christoph B Duesberg; Surbhi Malhotra-Kumar; Herman Goossens; Lesley McGee; Keith P Klugman; Tobias Welte; Mathias W R Pletz
Journal:  Antimicrob Agents Chemother       Date:  2008-09-02       Impact factor: 5.191

9.  Molecular characterization of emerging non-levofloxacin-susceptible pneumococci isolated from children in South Africa.

Authors:  Nicole Wolter; Mignon du Plessis; Anne von Gottberg; Linda de Gouveia; Keith P Klugman
Journal:  J Clin Microbiol       Date:  2009-03-04       Impact factor: 5.948

Review 10.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.